UCB signs up for Vault CRM as Veeva's CRM migration wave reaches Europe

Another big pharma name has signed up for the move. UCB has committed to Veeva Vault CRM, Veeva announced on 4 November, extending a partnership the two companies already have.

Financial terms weren't disclosed, and neither was a timeline for the switch.

Get Software in Science every TuesdayThree-minute read. Free. One-click unsubscribe.

What UCB is buying

Vault CRM is part of Veeva's Vault CRM Suite and comes with what Veeva calls industry-specific AI. The release highlights one feature in particular: an Agentic Call Report, which turns field interactions into what Veeva calls Commercial Evidence, aimed at surfacing treatment barriers that would otherwise go unnoticed.

"We are excited to strengthen our strategic partnership with Veeva by moving to Vault CRM." Edwin Erckens, chief digital technology officer, UCB

Chris Moore, president of Veeva Europe, described the platform as "a stable, scalable, and future-ready technology foundation that will advance UCB's commercial strategy."

Why it matters

Veeva is in the middle of moving the life sciences industry onto its own CRM platform. In September, its executives told investors that more than 180 customers were live on Vault CRM and that its CRM win rate outside the top 20 pharma companies was above 80% this year, according to MarketBeat. They also said they expect to keep more than 70% of the life sciences CRM market over time.

Big-name commitments like UCB's are what turn a win rate into market share. A European win also shows the migration isn't only a US story.

Veeva says it serves more than 1,500 customers. The UCB news landed the day before Veeva's virtual investor day on 5 November.

The bigger picture

CRM migrations are rarely quick. Field teams need retraining, data has to move, integrations get rebuilt, and in pharma every change has a compliance angle. Add agentic features such as AI call reporting and the work stretches beyond IT into commercial operations, medical and field leadership.

That makes the next couple of years busy for anyone who implements, configures or sells around Veeva's commercial stack. Systems integrators, consultancies and the CRM teams inside pharma companies will all be planning for the same pool of experienced people.

For Veeva itself, the story is momentum. Each named switch, especially outside the US, strengthens its case with the accounts still deciding.

What it means for hiring

Every big CRM switch needs people who've done one before. We'd expect strong demand for Vault CRM consultants, solution architects and project leads with pharma commercial experience.
Agentic features like AI call reporting pull commercial excellence and field operations leaders into the rollout. People who can translate AI output into field behaviour are scarce.
European migrations need local delivery teams with language skills and an understanding of EU compliance. That's a narrower pool than the US.

Share Ask Jack about this →